What matters most when the next cure is waiting to be discovered?

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.
We'd appreciate your feedback.Tell us what you think!
Embase is the biomedical database for systematic reviews, drug safety monitoring and evidence-based research and practice. Regulators and researchers worldwide rely on Embase for biomedical literature that is comprehensive and current.


Fast access to biological relationships and pathways to understand disease biology and get targeted data
The risk assessment tool for translational safety, drug efficacy and DMPK
Expertly curated chemical data and insights for better decision making
Elsevier's premiere platform of peer-reviewed scholarly literature

Embase supports rigorous systematic reviews with Embase AI and intuitive search tools on top of deeply indexed journals and comprehensive content. Embase is an abstract and indexing database specializing in medicine and biomedical science. Embase content includes records from journal articles, clinical trials, conference abstracts, conference papers, conference reviews, data papers, editorial, erratum, letters, notes, reviews and short surveys. AI-based search, guided PICO search forms and advanced queries help Embase users gain the critical insights needed to confidently evaluate existing evidence and publish original research.

Embase helps surface adverse drug events quickly with pharmacovigilance (PV) search tools on top of comprehensive biomedical content updated daily with 8,000 new records. Regulatory bodies recognize Embase as a source for discovering adverse events in post-market surveillance. A PV search form and tools to track drug-disease relations and drug-drug interactions support high-recall, high-precision drug safety monitoring. Don’t miss important information — set email alerts in Embase about drugs or other areas of interest to receive individual or group notifications.

Embase helps medical device companies comply with medical device regulations with medical device search tools on top of comprehensive medical device content. Embase creates detailed medical device records by indexing medical devices and relevant metadata, including medical device manufacturers, concepts and procedures, device trade names and GMDN. The medical device search form in Embase has preset terms, making it easy to create precise and high-recall queries for clinical evaluations, post-market surveillance and systematic reviews. Discover, innovate and develop with confidence using Embase.

Emtree — the Embase life sciences thesaurus — connects and surfaces related biomedical terms to deliver precise, thorough search results. Emtree has a rich controlled vocabulary of terms, synonyms, trade names and drug, disease and medical device subheadings to describe biomedical concepts consistently. Emtree maps biomedical synonyms and relationships in a robust taxonomy, so researchers can find relevant studies and avoid noise and bias. Learn more about Emtree.

Advance your R&D with Elsevier’s Embase and a portfolio of solutions for pharmaceutical and medical device R&D. Innovate with confidence, supported by:
Trusted quality information from peer-reviewed scientific literature to regulatory data
Innovative technology that powers data transformation, and analytical and predictive tools
Domain and data science expertise to solve complex problems with data solutions for R&D
Information integrity is essential to your progress. Discover trusted data and tools that deliver critical insights. (Learn more about responsible AI and data privacy in Elsevier AI tools.) Let's shape progress together.
Unlimited access for organizations
For government, institutions, corporate agencies, contract research organizations and consultancies
One user gets 30-day access to Embase.com (limited to four per year). Includes five email alerts.
For individuals, small and medium size businesses. Excludes contract research organizations and consultancies.
One user gets seven-day access to Embase.com (limited to four per year).
For individuals, small and medium size businesses. Excludes contract research organizations and consultancies.
Performing a systematic search of peer-reviewed and gray literature using Embase is generally accepted as a best practice for evidence-based medicine.
George R. Khachatryan
RosMedEx
Embase includes 99% of MEDLINE1 journals plus over 3,000 additional titles. Unlike MEDLINE, Embase covers conferences — more than 16,000 — providing earlier access to emerging biomedical research.
Embase indexes content more deeply than MEDLINE. The Embase life science thesaurus Emtree has more than 100,000 preferred terms (including MeSH terms) and 550,000 synonyms, compared with approximately 30,000 preferred terms in MeSH.
Deeper, granular indexing for medical devices and drugs in Embase helps researchers find the right evidence faster.
1. MEDLINE is a bibliographic database from the US National Library of Medicine and is the largest component of PubMed. MeSH (Medical Subject Headings) is the thesaurus used for indexing articles for PubMed. Source: National Library of Medicine website, accessed Nov. 18, 2025
Embase is recommended and/or referenced by competent authorities in the US, European Union, UK, Brazil, Australia, Canada and other nations.
Guidelines, best practices and agencies that recommend or reference Embase include:
EMA - Guideline on Good Pharmacovigilance Practices (GVP)
European Union Medical Device Regulation (EU MDR)
Cochrane Handbook for Systematic Reviews of Interventions, Version 6.2
WHO Handbook for Guideline Development
UK's NICE Interim Clinical Guideline Surveillance Process and Methods Guide
JBI Manuals for Evidence Synthesis and Evidence Implementation
Brazilian Ministry of Health
Therapeutic Goods Administration (TGA) Australia for Pharmacovigilance
European Network for Health Technology Assessment
Canada’s Drug Agency (CDA-AMC)
Embase provides deep biomedical evidence for regulatory compliance requiring comprehensive and current literature surveillance. Embase covers 99% of MEDLINE journals and 3,000+ more, with extensive European coverage. Conference abstracts and gray literature in Embase reveal new safety or performance data not available yet in peer-reviewed publications. Regulators expect transparent, documented literature review processes, which Embase supports through guided search forms, advanced filtering and exportable search histories. These features help users produce audit-ready documentation for submissions, inspections, and pharmacovigilance reports.
